Clinical Trial Detail

NCT ID NCT02788981
Title A Trial of Nanoparticle Albumin-Bound Paclitaxel (Nab-Paclitaxel, Abraxane) With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors University of Chicago
Indications

triple-receptor negative breast cancer

Therapies

Mifepristone + Nab-paclitaxel

nab-paclitaxel

Age Groups: adult

Additional content available in CKB BOOST